Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesBioPharma Credit PLC

BioPharma Credit PLC

Financial Services Asset Management
PortfolioPortfolio WatchlistWatchlist
Company price
0.976 GBX 0.00 ( 0.41%)
Last update at 2026-10-27T16:35:00Z
VOLUME
637042
Market Cap
106147.41M
P/E
0.09

Momentum Score

…

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.97
Low
0.98
High
52 Week Price Range
0.76
Low
0.97
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.97
Dividend Yield
7.49%
Revenue TTM
157.75M
Revenue Per Share
0.14
Gross Profit TTM
157.75M
Debt / Equity
-
ROE
11.14%
Net Debt
-12.59M
ROCE
11.25%
Diluted EPS TTM
0.11

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 129.89M 122.18M 108.45M 182.31M 84.96M
Net income 129.89M 122.18M 108.45M 182.31M 84.96M
Selling general administrative 2.30M 1.97M 1.86M 1.70M 2.86M
Selling and marketing expenses - 0.18M 0.17M 0.20M 0.20M
Gross profit 114.50M 124.46M 110.49M 184.25M 87.97M
Ebit - 244.36M 216.91M - 84.98M
Ebitda 129.89M 122.18M 108.45M 182.31M 84.96M
Depreciation and amortization - -122.18M -108.46M - -
Operating income 129.85M 122.18M 108.45M 182.31M 84.96M
Other operating expenses 10.38M 2.28M 51.23M 1.93M 3.01M
Interest expense - - - - 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 1.62M 1.49M 4.32M 1.15M 3.13M
Net interest income 1.62M 1.49M 4.32M 1.15M 3.13M
Income tax expense - - 108.45M - -
Total revenue 140.23M 124.46M 159.68M 184.25M 87.97M
Total operating expenses -15.35M 2.28M 2.04M 1.93M 3.01M
Cost of revenue 25.73M 25.57M 25.24M - -
Total other income expense net 0.04M 122.18M -0.01M - -
Net income from continuing ops 129.89M 122.18M 108.45M 182.31M 84.96M
Net income applicable to common shares - - - - 84.96M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1168.42M 1199.62M 1356.73M 1364.02M 1370.62M
Other current assets - -31.80M 0.09M - -
Total liab 17.56M 17.94M 15.87M 26.56M 6.34M
Total stockholder equity 1150.86M 1181.68M 1340.86M 1337.45M 1363.72M
Other current liab 14.43M 16.94M 15.87M 1.95M -6.34M
Common stock 13.74M 13.74M 13.74M 13.74M 13.74M
Capital stock 13.74M 13.74M 13.74M 13.74M 13.74M
Retained earnings 36.09M 560.81M 720.00M - 742.85M
Other liab - - - - 0.56M
Other assets - 1199.62M 48.85M - 1370.62M
Cash 12.59M 5.62M 86.20M 120.53M 94.71M
Total current liabilities 14.43M 17.88M 15.87M - 6.34M
Net debt -12.59M -5.62M -86.20M -120.53M -94.71M
Other stockholder equity 607.12M 607.12M 607.12M 1323.71M 1349.98M
Total current assets 66.19M 37.42M 155.37M 140.37M 104.72M
Long term investments 1102.23M 1162.20M 1201.36M 1223.65M 1265.90M
Net tangible assets - - - - 1363.72M
Short term investments - - 48.85M - -
Net receivables 53.60M 31.80M 20.23M 19.84M 10.01M
Inventory - - -0.09M - -
Accounts payable 0.00M 0.95M 0.00M - 6.34M
Accumulated other comprehensive income 493.91M - 0.00M - -
Non currrent assets other - -1162.20M -1201.36M -1223.65M -1265.90M
Non current assets total 1102.23M 1162.20M 1201.36M 1223.65M 1265.90M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 77.48M 39.07M -1.66M 48.19M -94.82M
Change to liabilities - - - 0.00M -2.49M
Total cashflows from investing activities 77.48M 39.07M -1.66M - -94.82M
Total cash from financing activities -161.65M -280.42M -106.99M -206.62M -100.16M
Net income 129.89M 122.18M 108.45M 182.31M 84.96M
Change in cash 6.97M -129.43M 14.53M 25.82M -98.56M
Begin period cash flow 5.62M 135.05M 120.53M 94.71M 193.27M
End period cash flow 12.59M 5.62M 135.05M 120.53M 94.71M
Total cash from operating activities 91.09M 111.91M 123.18M 184.28M 96.44M
Dividends paid 110.38M 174.66M 89.77M 156.54M 100.16M
Change to account receivables -21.80M -11.48M -0.48M - -9.80M
Sale purchase of stock -51.27M -105.75M -17.22M -50.09M 0.00M
Other cashflows from financing activities - - -1.66M 48.19M -94.82M
Change to netincome - - - - 23.77M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital -21.24M -10.36M -9.22M 7.88M -12.29M
Other non cash items -17.55M 0.09M 23.95M -5.92M 23.77M
Free cash flow 91.09M 111.91M 123.18M 184.28M 96.44M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
BPCR
BioPharma Credit PLC		 0.00
0.41%		 0.98 0.09 - 6.73 0.91 7.95
MNTN
Schiehallion Fund Ltd		 -0.01
0.46%		 2.18 0.05 - 4.35 1.25 5.65
BHMU
BH Macro Limited		 -
-%		 4.29 0.09 - 39.01 0.71 6.47
TFG
Tetragon Financial Group Ltd		 0.15
1.00%		 15.10 0.02 7.04 1.16 0.31 2.06
RTW
RTW Venture Fund Ltd		 0.06
2.58%		 2.39 0.03 - 19.21 0.76 2.61

Profile*

BioPharma Credit PLC

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom.

51 Lime Street, London, United Kingdom, EC3M 7DQ

44 13 9247 7500

https://www.bpcruk.com

Name Title Year Born
Mr. Pedro Gonzalez de Cosio Investment Mang. NA
Mr. Pablo Gerardo Legorreta Investment Mang. 1964
Mr. Martin G. Friedman Investment Mang. 1965
Mr. Pedro Gonzalez de Cosio Investment Manager NA
Mr. Pablo Legorreta Investment Manager 1963
Mr. Martin Friedman Investment Manager 1965

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…